SCHEDULE: FMR LLC Reports 7.4% Stake in Insmed Inc.

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 16,127,583 shares, representing 7.4% of Insmed Inc.'s common stock as of June 30, 2026.

Summary

• FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, indicating their beneficial ownership of Insmed Inc. common stock.
• As of June 30, 2026, the reporting persons collectively beneficially own 16,127,583 shares of Insmed Inc. common stock.
• This ownership stake represents 7.4% of the class of securities.
• FMR LLC is identified as a Delaware entity, and Abigail P. Johnson is a U.S. citizen.
• The filing indicates that FMR LLC and its subsidiaries, along with Abigail P. Johnson, are the reporting persons.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports a change in beneficial ownership percentage without providing new operational or financial performance data.

Positives

• FMR LLC and Abigail P. Johnson maintain a significant stake, indicating continued investor confidence or strategic interest in Insmed Inc.

Negatives

• No new operational or financial performance data is provided in this filing, limiting insights into the company's current health.

Risks

• The filing does not explicitly mention any new risks or challenges for Insmed Inc.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding future performance.

Management Comments

• FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant shareholders to report their holdings. This filing indicates FMR LLC's continued substantial investment in Insmed Inc., a biotechnology company.

Stakeholder Impact

• Shareholders may view the continued significant stake by FMR LLC as a sign of stability or potential future strategic interest in Insmed Inc.

Next Steps

• FMR LLC and Abigail P. Johnson will continue to report any material changes in their beneficial ownership of Insmed Inc. common stock as required by SEC regulations.

Key Dates

Keywords

Insmed Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management